Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT00967577
1:25:chronic_disease
Active serious infection
3
[ "Active", "serious", "infection" ]
[ 2, 2, 2 ]
NCT02394028
57:80:treatment
Any major episode of infection requiring treatment with intravenous antibiotics
3
[ "Any", "major", "episode", "of", "infection", "requiring", "treatment", "with", "intravenous", "antibiotics" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02501096
12:27:treatment,52:68:treatment,69:91:treatment
History of organ allograft (Participant has had an allogenic tissue/solid organ transplant)
3
[ "History", "of", "organ", "allograft", "(", "Participant", "has", "had", "an", "allogenic", "tissue/solid", "organ", "transplant", ")" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0 ]
NCT01990209
27:36:allergy_name
Known hypersensitivity to orteronel or to orteronel excipients, which are listed by formulation in the Investigator Brochure
3
[ "Known", "hypersensitivity", "to", "orteronel", "or", "to", "orteronel", "excipients", ",", "which", "are", "listed", "by", "formulation", "in", "the", "Investigator", "Brochure" ]
[ 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02263274
1:21:chronic_disease,,
Cognitive impairment (Intelligence Quotient <70)
3
[ "Cognitive", "impairment", "(", "Intelligence", "Quotient", "<", "70", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02479620
8:22:chronic_disease
Active foot infection
3
[ "Active", "foot", "infection" ]
[ 0, 2, 2 ]
NCT03143985
35:63:treatment
Major abnormalities identified by ECG or echocardiogram (ECHO), at the Investigator's discretion
3
[ "Major", "abnormalities", "identified", "by", "ECG", "or", "echocardiogram", "(", "ECHO", ")", ",", "at", "the", "Investigator", "'s", "discretion" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02967315
40:63:treatment,97:113:treatment,145:170:chronic_disease,193:211:treatment
Patients who have significant residual right-sided obstruction (i.e. patients who have residual RVOT obstruction or significant residual branch pulmonary artery stenosis), as it is shown that residual pulmonary stenosis may protect from RV dilation and from deterioration of the RV function
3
[ "Patients", "who", "have", "significant", "residual", "right-sided", "obstruction", "(", "i.e", ".", "patients", "who", "have", "residual", "RVOT", "obstruction", "or", "significant", "residual", "branch", "pulmonary", "artery", "stenosis", ")", ",", "as", "it", "is", "shown", "that", "residual", "pulmonary", "stenosis", "may", "protect", "from", "RV", "dilation", "and", "from", "deterioration", "of", "the", "RV", "function" ]
[ 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02981082
11:22:chronic_disease
Untreated sleep apnea
3
[ "Untreated", "sleep", "apnea" ]
[ 0, 2, 2 ]
NCT03153982
66:103:cancer,,,,,,337:356:treatment,388:416:treatment
Histologically or cytologically confirmed, primary or recurrent, head and neck squamous cell carcinoma, including variants. Patients must have at least one measureable lesion in accordance with RECIST 1.1 (tumor diameter ≥ 1 cm; short-axis lymph node diameter ≥ 1.5 cm) OR by caliper measurement (tumor diameter ≥ 1 cm). Any diagnostic pretreatment biopsy sample is acceptable including fine needle aspiration (FNA)
3
[ "Histologically", "or", "cytologically", "confirmed", ",", "primary", "or", "recurrent", ",", "head", "and", "neck", "squamous", "cell", "carcinoma", ",", "including", "variants", ".", "Patients", "must", "have", "at", "least", "one", "measureable", "lesion", "in", "accordance", "with", "RECIST", "1.1", "(", "tumor", "diameter", "≥", "1", "cm", ";", "short-axis", "lymph", "node", "diameter", "≥", "1.5", "cm", ")", "OR", "by", "caliper", "measurement", "(", "tumor", "diameter", "≥", "1", "cm", ")", ".", "Any", "diagnostic", "pretreatment", "biopsy", "sample", "is", "acceptable", "including", "fine", "needle", "aspiration", "(", "FNA", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0 ]
NCT02393794
,29:39:treatment
≤ 2 weeks prior to starting study drug
3
[ "≤", "2", "weeks", "prior", "to", "starting", "study", "drug" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02755116
1:17:chronic_disease
Seizure disorder
3
[ "Seizure", "disorder" ]
[ 2, 2 ]
NCT02046330
38:54:chronic_disease
Patients who suffer from generalized anxiety disorder
3
[ "Patients", "who", "suffer", "from", "generalized", "anxiety", "disorder" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT02607514
1:24:treatment,
Psychotropic medication use that has been stable for <3 months
3
[ "Psychotropic", "medication", "use", "that", "has", "been", "stable", "for", "<", "3", "months" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03073343
26:51:treatment,53:62:treatment,67:80:treatment,82:91:treatment
Receiving treatment with insulin sensitizing drugs (metformin) or sulfonylureas (glipizide, etc.)
3
[ "Receiving", "treatment", "with", "insulin", "sensitizing", "drugs", "(", "metformin", ")", "or", "sulfonylureas", "(", "glipizide", ",", "etc", ".", ")" ]
[ 0, 0, 0, 1, 1, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0 ]
NCT02379377
1:32:cancer
carcinoma in situ of the cervix
3
[ "carcinoma", "in", "situ", "of", "the", "cervix" ]
[ 3, 3, 3, 3, 3, 3 ]
NCT02210078
13:42:treatment
any type of autologous or allogeneic HSCT
3
[ "any", "type", "of", "autologous", "or", "allogeneic", "HSCT" ]
[ 0, 0, 0, 1, 1, 1, 1 ]
NCT02266329
8:18:treatment,
Use of butalbital within 4 weeks of beginning the preliminary screening period through the end of study involvement
3
[ "Use", "of", "butalbital", "within", "4", "weeks", "of", "beginning", "the", "preliminary", "screening", "period", "through", "the", "end", "of", "study", "involvement" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02176967
,,44:65:cancer,,
Patients less than 6 months of age with an adrenal primary tumor > 3.1 and < 5 cm in greatest diameter
3
[ "Patients", "less", "than", "6", "months", "of", "age", "with", "an", "adrenal", "primary", "tumor", ">", "3.1", "and", "<", "5", "cm", "in", "greatest", "diameter" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02983240
1:20:treatment
regional anesthesia
3
[ "regional", "anesthesia" ]
[ 1, 1 ]
NCT00291525
7:23:chronic_disease
Other terminal illness
3
[ "Other", "terminal", "illness" ]
[ 0, 2, 2 ]
NCT02796300
15:32:treatment
First de novo dialysis catheter placement or second catheter exchange, no more than 3 replacements on a same site
3
[ "First", "de", "novo", "dialysis", "catheter", "placement", "or", "second", "catheter", "exchange", ",", "no", "more", "than", "3", "replacements", "on", "a", "same", "site" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01445821
1:17:chronic_disease
Hepatitis B or C positive
3
[ "Hepatitis", "B", "or", "C", "positive" ]
[ 2, 2, 2, 2, 0 ]
NCT01373112
18:40:allergy_name,42:52:allergy_name,56:66:allergy_name
Known allergy to polymethylmethacrylate, tobramycin or vancomycin
3
[ "Known", "allergy", "to", "polymethylmethacrylate", ",", "tobramycin", "or", "vancomycin" ]
[ 0, 0, 0, 4, 0, 4, 0, 4 ]
NCT02553642
42:64:treatment
Subjects may have received any number of prior lines of therapy
3
[ "Subjects", "may", "have", "received", "any", "number", "of", "prior", "lines", "of", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT03152058
,24:34:treatment,
Women currently taking prednisone greater than 10 mg daily
3
[ "Women", "currently", "taking", "prednisone", "greater", "than", "10", "mg", "daily" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02315612
,,180:199:treatment
Patients of child-bearing or child-fathering potential must be willing to practice birth control from the time of enrollment on this study and for four months after receiving the preparative regimen
3
[ "Patients", "of", "child-bearing", "or", "child-fathering", "potential", "must", "be", "willing", "to", "practice", "birth", "control", "from", "the", "time", "of", "enrollment", "on", "this", "study", "and", "for", "four", "months", "after", "receiving", "the", "preparative", "regimen" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03058029
32:44:chronic_disease,
Change in medications treating dyslipidemia within one (1) month prior to Screening Visit
3
[ "Change", "in", "medications", "treating", "dyslipidemia", "within", "one", "(", "1", ")", "month", "prior", "to", "Screening", "Visit" ]
[ 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03014687
1:10:chronic_disease
hepatitis
3
[ "hepatitis" ]
[ 2 ]
NCT03071328
1:52:cancer
Small cell or neuroendocrine tumors of the prostate are also permitted
3
[ "Small", "cell", "or", "neuroendocrine", "tumors", "of", "the", "prostate", "are", "also", "permitted" ]
[ 3, 3, 3, 3, 3, 3, 3, 3, 0, 0, 0 ]
NCT03170401
1:21:chronic_disease
short bowel syndrome
3
[ "short", "bowel", "syndrome" ]
[ 2, 2, 2 ]
NCT01532687
,39:49:treatment
within 28 days prior to first dose of study drug
3
[ "within", "28", "days", "prior", "to", "first", "dose", "of", "study", "drug" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT00967577
1:69:treatment,76:85:treatment,88:97:treatment
Prior treatment with 89Strontium or 153Samarium containing compounds (e.g. Metastron®, Quadramet®)
3
[ "Prior", "treatment", "with", "89Strontium", "or", "153Samarium", "containing", "compounds", "(", "e.g", ".", "Metastron®", ",", "Quadramet®", ")" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 1, 0, 1, 0 ]
NCT02414269
30:39:treatment,55:72:cancer,89:105:treatment,116:129:cancer
Patients currently receiving treatment for concurrent active malignancy Continuation of hormonal therapy (i.e. for breast cancer)
3
[ "Patients", "currently", "receiving", "treatment", "for", "concurrent", "active", "malignancy", "Continuation", "of", "hormonal", "therapy", "(", "i.e", ".", "for", "breast", "cancer", ")" ]
[ 0, 0, 0, 1, 0, 0, 3, 3, 0, 0, 1, 1, 0, 0, 0, 0, 3, 3, 0 ]
NCT01042522
40:61:cancer,63:83:cancer,85:115:cancer,117:142:cancer,144:157:cancer,160:186:cancer,188:204:cancer,219:241:cancer,243:257:cancer
Patients with histologically confirmed ovarian stromal tumor [granulosa cell tumor, ganulosa cell-theca cell tumor, Sertoli-Leydig cell tumor (androblastoma), steroid (lipid) cell tumor, gynandroblastoma, unclassified sex cord-stromal tumor, sex cord tumor with annular tubules]
3
[ "Patients", "with", "histologically", "confirmed", "ovarian", "stromal", "tumor", "[", "granulosa", "cell", "tumor", ",", "ganulosa", "cell-theca", "cell", "tumor", ",", "Sertoli-Leydig", "cell", "tumor", "(", "androblastoma", ")", ",", "steroid", "(", "lipid", ")", "cell", "tumor", ",", "gynandroblastoma", ",", "unclassified", "sex", "cord-stromal", "tumor", ",", "sex", "cord", "tumor", "with", "annular", "tubules", "]" ]
[ 0, 0, 0, 0, 3, 3, 3, 0, 3, 3, 3, 0, 3, 3, 3, 3, 0, 3, 3, 3, 0, 3, 0, 0, 3, 3, 3, 3, 0, 0, 0, 3, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01876511
1:20:chronic_disease
Progressive disease
3
[ "Progressive", "disease" ]
[ 2, 2 ]
NCT02595372
8:16:treatment,
Use of OTC PPIs within 6 months prior to study entry
3
[ "Use", "of", "OTC", "PPIs", "within", "6", "months", "prior", "to", "study", "entry" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT03174834
9:27:treatment
Current antibiotic therapy
3
[ "Current", "antibiotic", "therapy" ]
[ 0, 1, 1 ]
NCT02446457
,,,,175:191:treatment
willing to use 2 methods of birth control or be surgically sterile, or abstain from heterosexual activity for the course of the study through 120 days after the last dose of study medication
3
[ "willing", "to", "use", "2", "methods", "of", "birth", "control", "or", "be", "surgically", "sterile", ",", "or", "abstain", "from", "heterosexual", "activity", "for", "the", "course", "of", "the", "study", "through", "120", "days", "after", "the", "last", "dose", "of", "study", "medication" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02315196
15:24:treatment,30:45:treatment,37:45:treatment,,,85:103:treatment
this includes treatment with corticosteroids within one month (dose of >= 10 mg/day methylprednisolone equivalent) (excluding inhaled steroids)
3
[ "this", "includes", "treatment", "with", "corticosteroids", "within", "one", "month", "(", "dose", "of", ">", "=", "10", "mg/day", "methylprednisolone", "equivalent", ")", "(", "excluding", "inhaled", "steroids", ")" ]
[ 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0 ]
NCT02272556
1:10:chronic_disease,16:21:treatment,35:44:treatment,46:58:treatment,60:67:treatment,100:118:chronic_disease,,,
Type 2 DM with HbA1C treated with metformin, sulfonylurea, insulin, or combination OR age-matched, non-diabetic obese (BMI > 30 kg/m^2) OR age-matched lean, healthy control subjects (BMI < 25 kg/m^2)
3
[ "Type", "2", "DM", "with", "HbA1C", "treated", "with", "metformin", ",", "sulfonylurea", ",", "insulin", ",", "or", "combination", "OR", "age-matched", ",", "non-diabetic", "obese", "(", "BMI", ">", "30", "kg/m^2", ")", "OR", "age-matched", "lean", ",", "healthy", "control", "subjects", "(", "BMI", "<", "25", "kg/m^2", ")" ]
[ 2, 2, 2, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02476409
29:40:chronic_disease
Hemodynamically significant arrhythmias
3
[ "Hemodynamically", "significant", "arrhythmias" ]
[ 0, 0, 2 ]
NCT02008656
22:35:cancer
Primary unresectable rectal cancer
3
[ "Primary", "unresectable", "rectal", "cancer" ]
[ 0, 0, 3, 3 ]
NCT00001379
1:24:treatment
DA-Epoch-R chemotherapy
3
[ "DA-Epoch-R", "chemotherapy" ]
[ 1, 1 ]
NCT02585973
1:32:cancer
carcinoma in situ of the cervix
3
[ "carcinoma", "in", "situ", "of", "the", "cervix" ]
[ 3, 3, 3, 3, 3, 3 ]
NCT01880567
21:24:cancer
Relapsed/refractory MCL: Patients with bone marrow or gastrointestinal (GI) only involvement
3
[ "Relapsed/refractory", "MCL", ":", "Patients", "with", "bone", "marrow", "or", "gastrointestinal", "(", "GI", ")", "only", "involvement" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02433977
29:42:treatment,
Use of mouthwash containing chlorhexidine (lowers NO) within 1 week prior to screening and throughout the study
3
[ "Use", "of", "mouthwash", "containing", "chlorhexidine", "(", "lowers", "NO", ")", "within", "1", "week", "prior", "to", "screening", "and", "throughout", "the", "study" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02541903
23:32:treatment,34:41:treatment,75:90:treatment,,181:190:treatment
have completed local (radiation) therapy and have discontinued the use of corticosteroids or have been on stable dose of corticosteroids for at least 4 weeks before starting study treatment
3
[ "have", "completed", "local", "(", "radiation", ")", "therapy", "and", "have", "discontinued", "the", "use", "of", "corticosteroids", "or", "have", "been", "on", "stable", "dose", "of", "corticosteroids", "for", "at", "least", "4", "weeks", "before", "starting", "study", "treatment" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02401347
13:50:chronic_disease
Known to be human immunodeficiency virus positive
3
[ "Known", "to", "be", "human", "immunodeficiency", "virus", "positive" ]
[ 0, 0, 0, 2, 2, 2, 2 ]
NCT01919619
27:38:allergy_name,40:52:allergy_name,56:66:allergy_name
Known hypersensitivity to thalidomide, lenalidomide or ipilimumab
3
[ "Known", "hypersensitivity", "to", "thalidomide", ",", "lenalidomide", "or", "ipilimumab" ]
[ 0, 0, 0, 4, 0, 4, 0, 4 ]
NCT02699697
74:83:treatment,131:133:cancer,135:137:cancer,142:144:cancer,
those patients will still be eligible but will be considered to have two treatment sites; for example, a patient with a lesion of T4, T7 and T9 would be eligible but would be considered as two treatment sites since more than five consecutive vertebral bodies would be treated
3
[ "those", "patients", "will", "still", "be", "eligible", "but", "will", "be", "considered", "to", "have", "two", "treatment", "sites", ";", "for", "example", ",", "a", "patient", "with", "a", "lesion", "of", "T4", ",", "T7", "and", "T9", "would", "be", "eligible", "but", "would", "be", "considered", "as", "two", "treatment", "sites", "since", "more", "than", "five", "consecutive", "vertebral", "bodies", "would", "be", "treated" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02576444
1:18:treatment,34:37:treatment,141:160:treatment,162:185:treatment,190:219:treatment
Molecular testing or appropriate IHC results from CLIA-certified laboratories used for patient eligibility should be obtained from the most recent tumor biopsy (baseline tumor biopsies and on-progression tumor biopsies are optional)
3
[ "Molecular", "testing", "or", "appropriate", "IHC", "results", "from", "CLIA-certified", "laboratories", "used", "for", "patient", "eligibility", "should", "be", "obtained", "from", "the", "most", "recent", "tumor", "biopsy", "(", "baseline", "tumor", "biopsies", "and", "on-progression", "tumor", "biopsies", "are", "optional", ")" ]
[ 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 1, 1, 0, 1, 1, 1, 0, 0, 0 ]
NCT02349958
1:45:cancer
Recurrent or primary gastrointestinal cancer, with regional spread confined to the peritoneal cavity
3
[ "Recurrent", "or", "primary", "gastrointestinal", "cancer", ",", "with", "regional", "spread", "confined", "to", "the", "peritoneal", "cavity" ]
[ 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02340156
1:13:cancer,17:28:cancer,42:54:cancer
Glioblastoma or gliosarcoma disease with leptomeningeal spread
3
[ "Glioblastoma", "or", "gliosarcoma", "disease", "with", "leptomeningeal", "spread" ]
[ 3, 3, 3, 3, 3, 3, 3 ]
NCT02929589
28:37:chronic_disease
Subjects with a history of cirrhosis
3
[ "Subjects", "with", "a", "history", "of", "cirrhosis" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT03104205
12:29:treatment
History of bariatric surgery
3
[ "History", "of", "bariatric", "surgery" ]
[ 0, 0, 1, 1 ]
NCT03030859
1:24:chronic_disease
sensitive carotid sinus
3
[ "sensitive", "carotid", "sinus" ]
[ 2, 2, 2 ]
NCT02932280
,14:28:treatment
60 days from allogeneic SCT
3
[ "60", "days", "from", "allogeneic", "SCT" ]
[ 0, 0, 0, 1, 1 ]
NCT02454907
12:15:treatment,28:35:treatment,124:134:treatment,160:163:treatment
History of DMT exposure if MAGNIMS 2010 criteria used to enroll patients with disease onset in the past year, or change in MS therapy since qualifying relapse/MRI criteria occurred
3
[ "History", "of", "DMT", "exposure", "if", "MAGNIMS", "2010", "criteria", "used", "to", "enroll", "patients", "with", "disease", "onset", "in", "the", "past", "year", ",", "or", "change", "in", "MS", "therapy", "since", "qualifying", "relapse/MRI", "criteria", "occurred" ]
[ 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0 ]
NCT02390752
1:9:treatment,11:32:treatment,,76:90:treatment
Biologic (anti-neoplastic agent): At least 7 days after the last dose of a biologic agent
3
[ "Biologic", "(", "anti-neoplastic", "agent", ")", ":", "At", "least", "7", "days", "after", "the", "last", "dose", "of", "a", "biologic", "agent" ]
[ 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01983462
30:37:treatment,39:45:treatment,71:80:treatment,82:89:treatment,92:107:treatment,109:121:treatment,123:138:treatment,142:162:treatment
Taking lipid lowering (e.g., statins, niacin), glycemic control (e.g. metformin, insulin), anticoagulation, anti-seizure, anti-depression or antipsychotic agents
3
[ "Taking", "lipid", "lowering", "(", "e.g.", ",", "statins", ",", "niacin", ")", ",", "glycemic", "control", "(", "e.g", ".", "metformin", ",", "insulin", ")", ",", "anticoagulation", ",", "anti-seizure", ",", "anti-depression", "or", "antipsychotic", "agents" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0, 1, 1 ]
NCT02819141
1:28:chronic_disease,
Acute myocardial infarction within 48 hours prior to enrollment
3
[ "Acute", "myocardial", "infarction", "within", "48", "hours", "prior", "to", "enrollment" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT03188185
28:35:chronic_disease
Has a significant risk for suicide
3
[ "Has", "a", "significant", "risk", "for", "suicide" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT02469857
1:4:chronic_disease,,,
CHF {NYHA class III-IV}
3
[ "CHF", "{", "NYHA", "class", "III-IV", "}" ]
[ 2, 0, 0, 0, 0, 0 ]
NCT02454517
26:56:cancer,,,,,,
Histologically confirmed adenocarcinoma of the prostate, clinically localized, low or low-intermediate risk disease (T1C/T2a, Gleason =< 7 [3+4], prostate-specific antigen [PSA] < 20)
3
[ "Histologically", "confirmed", "adenocarcinoma", "of", "the", "prostate", ",", "clinically", "localized", ",", "low", "or", "low-intermediate", "risk", "disease", "(", "T1C/T2a", ",", "Gleason", "=", "<", "7", "[", "3+4", "]", ",", "prostate-specific", "antigen", "[", "PSA", "]", "<", "20", ")" ]
[ 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03181893
10:12:chronic_disease
Positive DM serology
3
[ "Positive", "DM", "serology" ]
[ 0, 2, 0 ]
NCT03008616
24:37:chronic_disease
Clinically significant fetal anomaly
3
[ "Clinically", "significant", "fetal", "anomaly" ]
[ 0, 0, 2, 2 ]
NCT02064036
8:19:treatment,
Use of finasteride within 30 days prior to registration
3
[ "Use", "of", "finasteride", "within", "30", "days", "prior", "to", "registration" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02338232
1:26:cancer
Chronic lymphoid leukemia
3
[ "Chronic", "lymphoid", "leukemia" ]
[ 3, 3, 3 ]
NCT02404870
13:26:chronic_disease,,,75:98:chronic_disease,102:125:chronic_disease,127:133:cancer,135:143:chronic_disease,155:179:chronic_disease,199:243:chronic_disease,245:260:chronic_disease
Presence of heart disease, untreated high blood pressure (>140/90 mm Hg), orthostatic hypotension or symptomatic hypotension, cancer, diabetes, recurrent symptomatic hypoglycemia and /or history of recurrent genital or urinary tract infection, thyroid disease, or any other condition that affects bone health
3
[ "Presence", "of", "heart", "disease", ",", "untreated", "high", "blood", "pressure", "(", ">", "140/90", "mm", "Hg", ")", ",", "orthostatic", "hypotension", "or", "symptomatic", "hypotension", ",", "cancer", ",", "diabetes", ",", "recurrent", "symptomatic", "hypoglycemia", "and", "/or", "history", "of", "recurrent", "genital", "or", "urinary", "tract", "infection", ",", "thyroid", "disease", ",", "or", "any", "other", "condition", "that", "affects", "bone", "health" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 3, 0, 2, 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01524536
,42:52:treatment,
Receiving less than or equal to 10 mg of prednisone or equivalent but have not been on a fixed dose for at least 3 weeks
3
[ "Receiving", "less", "than", "or", "equal", "to", "10", "mg", "of", "prednisone", "or", "equivalent", "but", "have", "not", "been", "on", "a", "fixed", "dose", "for", "at", "least", "3", "weeks" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02312596
10:19:treatment,21:30:treatment,34:43:treatment,
Received allograft, autograft or xenograft within 30 days of enrollment
3
[ "Received", "allograft", ",", "autograft", "or", "xenograft", "within", "30", "days", "of", "enrollment" ]
[ 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0 ]
NCT03058796
1:23:chronic_disease
traumatic brain injury
3
[ "traumatic", "brain", "injury" ]
[ 2, 2, 2 ]
NCT02339922
,,,63:74:chronic_disease,92:97:cancer,,,,210:226:chronic_disease,288:300:chronic_disease,304:335:chronic_disease
Absolute neutrophil count (ANC) > 1,000/mm^3 or > 500/mm^3 if neutropenia is attributed to B-NHL (involvement of bone marrow) without growth factor support and platelet count > 100,000/mm3 or > 75,000/mm^3 if thrombocytopenia is attributed to B-NHL (involvement of bone marrow or due to splenomegaly or immune thrombocytopenic purpura)
3
[ "Absolute", "neutrophil", "count", "(", "ANC", ")", ">", "1,000/mm^3", "or", ">", "500/mm^3", "if", "neutropenia", "is", "attributed", "to", "B-NHL", "(", "involvement", "of", "bone", "marrow", ")", "without", "growth", "factor", "support", "and", "platelet", "count", ">", "100,000/mm3", "or", ">", "75,000/mm^3", "if", "thrombocytopenia", "is", "attributed", "to", "B-NHL", "(", "involvement", "of", "bone", "marrow", "or", "due", "to", "splenomegaly", "or", "immune", "thrombocytopenic", "purpura", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2, 0 ]
NCT02438904
50:75:treatment
Patients who have poor or no graft function post stem cell transplantation
3
[ "Patients", "who", "have", "poor", "or", "no", "graft", "function", "post", "stem", "cell", "transplantation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02588612
20:36:cancer,40:65:cancer,98:114:cancer,134:147:treatment,155:169:treatment,177:186:treatment,
Subject has active brain metastases or leptomeningeal metastases. Subjects with prior history of brain metastasis who have undergone local therapy (i.e., metastatectomy and/or radiation) and show no evidence of local recurrence or progression over the past 3 months prior to Screening are eligible
3
[ "Subject", "has", "active", "brain", "metastases", "or", "leptomeningeal", "metastases", ".", "Subjects", "with", "prior", "history", "of", "brain", "metastasis", "who", "have", "undergone", "local", "therapy", "(", "i.e.", ",", "metastatectomy", "and/or", "radiation", ")", "and", "show", "no", "evidence", "of", "local", "recurrence", "or", "progression", "over", "the", "past", "3", "months", "prior", "to", "Screening", "are", "eligible" ]
[ 0, 0, 0, 3, 3, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02796209
20:38:chronic_disease
History of serious neurologic disease
3
[ "History", "of", "serious", "neurologic", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT01365169
1:35:chronic_disease
Myopathic or rheumatologic disease that impacts physical function (PCS study)
3
[ "Myopathic", "or", "rheumatologic", "disease", "that", "impacts", "physical", "function", "(", "PCS", "study", ")" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03006302
16:42:cancer
Significant or malignant pleural effusion
3
[ "Significant", "or", "malignant", "pleural", "effusion" ]
[ 0, 0, 3, 3, 3 ]
NCT02487797
120:137:treatment
The participant's attending obstetric physician or midwife has determined that the participant needs administration of oxytocin infusion for labor augmentation
3
[ "The", "participant", "'s", "attending", "obstetric", "physician", "or", "midwife", "has", "determined", "that", "the", "participant", "needs", "administration", "of", "oxytocin", "infusion", "for", "labor", "augmentation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT03166371
12:60:chronic_disease,179:207:treatment,209:229:chronic_disease,231:257:chronic_disease,259:273:chronic_disease,275:301:chronic_disease,306:345:chronic_disease
History of acute or chronic gastrointestinal tract disorder that, in the opinion of the principal investigator would preclude ingestion or absorption of the study product (e.g., prior gastric bypass surgery, short bowel syndrome, inflammatory bowel disease, celiac disease, acute/chronic pancreatitis, or chronic upper gastrointestinal bleeding
3
[ "History", "of", "acute", "or", "chronic", "gastrointestinal", "tract", "disorder", "that", ",", "in", "the", "opinion", "of", "the", "principal", "investigator", "would", "preclude", "ingestion", "or", "absorption", "of", "the", "study", "product", "(", "e.g.", ",", "prior", "gastric", "bypass", "surgery", ",", "short", "bowel", "syndrome", ",", "inflammatory", "bowel", "disease", ",", "celiac", "disease", ",", "acute/chronic", "pancreatitis", ",", "or", "chronic", "upper", "gastrointestinal", "bleeding" ]
[ 0, 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT01864109
10:22:treatment,27:36:treatment,44:66:chronic_disease,70:87:chronic_disease
emergent radiotherapy for treatment of eg. spinal cord compromise or threatened airway
3
[ "emergent", "radiotherapy", "for", "treatment", "of", "eg", ".", "spinal", "cord", "compromise", "or", "threatened", "airway" ]
[ 0, 1, 0, 1, 0, 0, 0, 2, 2, 2, 0, 2, 2 ]
NCT02361554
26:35:treatment,,233:273:chronic_disease,343:367:treatment,398:407:treatment
Subject determined to be treatment-resistant for at least one year prior to the Screening Visit as demonstrated by clinical evidence (determined by review of medical records and discussion with referring psychiatrist) of persistent auditory hallucinations and/or delusions that have not responded to treatment with three adequate regimens of antipsychotic medication including one failed trial of clozapine
3
[ "Subject", "determined", "to", "be", "treatment-resistant", "for", "at", "least", "one", "year", "prior", "to", "the", "Screening", "Visit", "as", "demonstrated", "by", "clinical", "evidence", "(", "determined", "by", "review", "of", "medical", "records", "and", "discussion", "with", "referring", "psychiatrist", ")", "of", "persistent", "auditory", "hallucinations", "and/or", "delusions", "that", "have", "not", "responded", "to", "treatment", "with", "three", "adequate", "regimens", "of", "antipsychotic", "medication", "including", "one", "failed", "trial", "of", "clozapine" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1 ]
NCT01908777
1:6:cancer
EaTCL
3
[ "EaTCL" ]
[ 3 ]
NCT01850355
21:43:chronic_disease
Clinically unstable psychiatric conditions or judged to be at serious suicidal risk
3
[ "Clinically", "unstable", "psychiatric", "conditions", "or", "judged", "to", "be", "at", "serious", "suicidal", "risk" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02296684
,,,,,,259:266:treatment
Sexually active women of childbearing potential and men must agree to use 2 methods of contraception (hormonal or barrier method of birth control, abstinence) prior to study entry, for the duration of study participation, and for 120 days after last dose of MK-3475
3
[ "Sexually", "active", "women", "of", "childbearing", "potential", "and", "men", "must", "agree", "to", "use", "2", "methods", "of", "contraception", "(", "hormonal", "or", "barrier", "method", "of", "birth", "control", ",", "abstinence", ")", "prior", "to", "study", "entry", ",", "for", "the", "duration", "of", "study", "participation", ",", "and", "for", "120", "days", "after", "last", "dose", "of", "MK-3475" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02771626
1:13:treatment,15:48:treatment,50:67:treatment,71:87:treatment,
Chemotherapy, Tyrosine Kinase Inhibitor therapy, radiation therapy or hormonal therapy within 2 weeks
3
[ "Chemotherapy", ",", "Tyrosine", "Kinase", "Inhibitor", "therapy", ",", "radiation", "therapy", "or", "hormonal", "therapy", "within", "2", "weeks" ]
[ 1, 0, 1, 1, 1, 1, 0, 1, 1, 0, 1, 1, 0, 0, 0 ]
NCT03139227
36:48:allergy_name,62:66:allergy_name,68:75:allergy_name,86:90:allergy_name,101:107:allergy_name,117:130:allergy_name
No known allergy to ingredients of banana bread preparation (eggs, almonds and other nuts since the celery also has almond powder)
3
[ "No", "known", "allergy", "to", "ingredients", "of", "banana", "bread", "preparation", "(", "eggs", ",", "almonds", "and", "other", "nuts", "since", "the", "celery", "also", "has", "almond", "powder", ")" ]
[ 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 4, 0, 4, 0, 0, 4, 0, 0, 4, 0, 0, 4, 4, 0 ]
NCT02594501
11:28:chronic_disease
suspected aortic dissection
3
[ "suspected", "aortic", "dissection" ]
[ 0, 2, 2 ]
NCT02578641
1:27:cancer
cervical carcinoma in situ
3
[ "cervical", "carcinoma", "in", "situ" ]
[ 3, 3, 3, 3 ]
NCT02671435
24:36:cancer
with selected advanced solid tumors
3
[ "with", "selected", "advanced", "solid", "tumors" ]
[ 0, 0, 0, 3, 3 ]
NCT02581215
,,169:180:treatment
If sexually active, must be postmenopausal, surgically sterile, or using effective contraception (hormonal or barrier methods) due to unknown risk of teratogenicity of ramucirumab
3
[ "If", "sexually", "active", ",", "must", "be", "postmenopausal", ",", "surgically", "sterile", ",", "or", "using", "effective", "contraception", "(", "hormonal", "or", "barrier", "methods", ")", "due", "to", "unknown", "risk", "of", "teratogenicity", "of", "ramucirumab" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01536522
23:34:chronic_disease,38:53:chronic_disease,133:156:chronic_disease,179:192:chronic_disease
Any other significant respiratory or cardiac disease or the presence of clinically important comorbidities, including, uncontrolled coronary artery disease, acute or and chronic renal failure
3
[ "Any", "other", "significant", "respiratory", "or", "cardiac", "disease", "or", "the", "presence", "of", "clinically", "important", "comorbidities", ",", "including", ",", "uncontrolled", "coronary", "artery", "disease", ",", "acute", "or", "and", "chronic", "renal", "failure" ]
[ 0, 0, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 2, 2 ]
NCT03038620
16:47:treatment,
Receipt of any anti-obesity drug or supplement within 1 month prior to screening for this trial
3
[ "Receipt", "of", "any", "anti-obesity", "drug", "or", "supplement", "within", "1", "month", "prior", "to", "screening", "for", "this", "trial" ]
[ 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02860000
4:19:treatment,28:51:treatment,63:71:treatment,75:102:treatment
No prior treatment with an aurora Kinase inhibitor (either an aurora A or pan-aurora kinase inhibitor)
3
[ "No", "prior", "treatment", "with", "an", "aurora", "Kinase", "inhibitor", "(", "either", "an", "aurora", "A", "or", "pan-aurora", "kinase", "inhibitor", ")" ]
[ 0, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0 ]
NCT02708836
21:50:treatment
Patients undergoing elective laparoscopic surgery
3
[ "Patients", "undergoing", "elective", "laparoscopic", "surgery" ]
[ 0, 0, 1, 1, 1 ]
NCT02095184
26:54:cancer
Histologically confirmed adenocarcinoma of the breast
3
[ "Histologically", "confirmed", "adenocarcinoma", "of", "the", "breast" ]
[ 0, 0, 3, 3, 3, 3 ]
NCT02520713
1:13:cancer
brain tumors
3
[ "brain", "tumors" ]
[ 3, 3 ]
NCT02120222
8:31:chronic_disease
HBsAg (hepatitis B virus [HBV] surface antigen)
3
[ "HBsAg", "(", "hepatitis", "B", "virus", "[", "HBV", "]", "surface", "antigen", ")" ]
[ 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02013154
1:32:treatment,22:32:treatment,46:64:treatment
Prior treatment with paclitaxel as part of a definitive therapy regimen is acceptable. Patients who are unable to receive paclitaxel for any reason will be allowed to receive DKN-01 as a single agent
3
[ "Prior", "treatment", "with", "paclitaxel", "as", "part", "of", "a", "definitive", "therapy", "regimen", "is", "acceptable", ".", "Patients", "who", "are", "unable", "to", "receive", "paclitaxel", "for", "any", "reason", "will", "be", "allowed", "to", "receive", "DKN-01", "as", "a", "single", "agent" ]
[ 1, 1, 1, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]